Cargando…

Engineering Next-Generation CAR-T Cells for Better Toxicity Management

Immunoadoptive therapy with genetically modified T lymphocytes expressing chimeric antigen receptors (CARs) has revolutionized the treatment of patients with hematologic cancers. Although clinical outcomes in B-cell malignancies are impressive, researchers are seeking to enhance the activity, persis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrea, Alain E., Chiron, Andrada, Bessoles, Stéphanie, Hacein-Bey-Abina, Salima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696189/ https://www.ncbi.nlm.nih.gov/pubmed/33207607 http://dx.doi.org/10.3390/ijms21228620

Ejemplares similares

Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment
por: Andrea, Alain E., et al.
Publicado: (2022)

Gene therapy for severe combined immunodeficiencies and beyond
por: Fischer, Alain, et al.
Publicado: (2019)

Combination of thermal ablation by focused ultrasound, pFAR4-IL-12 transfection and lipidic adjuvant provide a distal immune response
por: Do, Hai Doan, et al.
Publicado: (2022)

Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs
por: Moghanloo, Ehsan, et al.
Publicado: (2021)

Engineering the next generation of CAR-NK immunotherapies
por: Biederstädt, Alexander, et al.
Publicado: (2021)

Anti-RNP positivity in primary Sjögren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement
por: Abbara, Salam, et al.
Publicado: (2019)

Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer i-TRACK10(®) to Monitor Infliximab and Adalimumab Serum trough Levels and Anti-Drug Antibodies
por: Berger, Anne Emmanuelle, et al.
Publicado: (2022)

Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF
por: Cachen, Laurie, et al.
Publicado: (2022)

Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
por: Yu, Tao, et al.
Publicado: (2022)

Early blood neurofilament light chain and myelin oligodendrocyte glycoprotein antibody levels associate with different disease courses of myelin oligodendrocyte glycoprotein-associated disease in children
por: Horellou, Philippe, et al.
Publicado: (2023)

Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
por: Dimitri, Alexander, et al.
Publicado: (2022)

A Machine Learning Approach for High-Dimensional Time-to-Event Prediction With Application to Immunogenicity of Biotherapies in the ABIRISK Cohort
por: Duhazé, Julianne, et al.
Publicado: (2020)

DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer
por: Wang, Gary P., et al.
Publicado: (2008)

Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children
por: Horellou, Philippe, et al.
Publicado: (2021)

Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
por: Charrier, Sabine, et al.
Publicado: (2019)

Assessing the effect of genetic markers on drug immunogenicity from a mechanistic model-based approach
por: Duhazé, Julianne, et al.
Publicado: (2020)

Real-Time Definition of Non-Randomness in the Distribution of Genomic Events
por: Abel, Ulrich, et al.
Publicado: (2007)

CAR models: next-generation CAR modifications for enhanced T-cell function
por: Abate-Daga, Daniel, et al.
Publicado: (2016)

A method to sequence and quantify DNA integration for monitoring outcome in gene therapy
por: Brady, Troy, et al.
Publicado: (2011)

Activation-induced cytidine deaminase prevents pro-B cell acute lymphoblastic leukemia by functioning as a negative regulator in Rag1 deficient pro-B cells
por: Auer, Franziska, et al.
Publicado: (2017)

Time to evolve: predicting engineered T cell-associated toxicity with next-generation models
por: Donnadieu, Emmanuel, et al.
Publicado: (2022)

Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
por: Petersen, Christopher T., et al.
Publicado: (2019)

Next generations of CAR-T cells - new therapeutic opportunities in hematology?
por: Tomasik, Jaromir, et al.
Publicado: (2022)

Toxicity and management in CAR T-cell therapy
por: Bonifant, Challice L, et al.
Publicado: (2016)

CAR-T: What Is Next?
por: Chen, Yi-Ju, et al.
Publicado: (2023)

Plasma Robot Engineering: The Next Generation of Precision Disease Management
por: Dai, Xiaofeng, et al.
Publicado: (2021)

Teaching an old dog new tricks: next-generation CAR T cells
por: Tokarew, Nicholas, et al.
Publicado: (2018)

Adaptor CAR Platforms—Next Generation of T Cell-Based Cancer Immunotherapy
por: Arndt, Claudia, et al.
Publicado: (2020)

Toxicity management strategies for next-generation novel therapeutics in multiple myeloma
por: Steinbach, Mary, et al.
Publicado: (2022)

Low Percentage of Signal Regulatory Protein α/β(+) Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients
por: Magill, Laura, et al.
Publicado: (2018)

Quest for next-generation search engine
Publicado: (2009)

318 Building A Better CAR: Improving CAR-T Trafficking in Cancer Therapy
por: Hong, Yeonsun, et al.
Publicado: (2022)

Gene modification strategies for next-generation CAR T cells against solid cancers
por: Tian, Yonggui, et al.
Publicado: (2020)

Next frontiers in CAR T-cell therapy
por: Brown, Christine E, et al.
Publicado: (2016)

CAR T Cell Toxicity: Current Management and Future Directions
por: Yáñez, Lucrecia, et al.
Publicado: (2019)

Next-Generation Nutritional Biomarkers to Guide Better Health Care
por: Redi, CarloAlberto
Publicado: (2016)

Next-generation nutritional biomarkers to guide better health care
por: Mani, Indu, et al.
Publicado: (2017)

Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease
por: Matei, Diana E., et al.
Publicado: (2021)

New insights in COVID-19–associated chilblains: A comparative study with chilblain lupus erythematosus
por: Battesti, Gilles, et al.
Publicado: (2020)

INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions
por: Berry, Charles C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ad4s37g3qc6hkug4shtblkst53